Thieler Law Corp advises investors with losses exceeding $100,000 of the March 7, 2017 lead plaintiff deadline in a class action lawsuit filed against Agile Therapeutics Inc (NASDAQ: AGRX) (“Agile Therapeutics” or “the Company”). The suit is pending in the U.S. District Court for the District of New Jersey and investors, who purchased Agile Therapeutics Inc securities between March 9, 2016 and January 3, 2017, have until March 7, 2017 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Agile Therapeutics Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that the Twirla contraceptive patch had an efficacy rating that fell below peer group standards; over half of patients in its “Secure” Phase 3 Study discontinued the study early; the Twirla patch therefore allegedly had a slight chance of FDA approval; and as a result, defendants’ positive statements about Agile Therapeutics business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

On January 3, 2017, the Company released data from its Phase 3 SECURE study evaluating the Company's contraceptive patch, Twirla.  The study failed to meet standards achieved by other existing marketed contraceptive patches. Among the results, Agile Therapeutics stated that 51.4% of subjects had withdrawn from the study and that 1.7% of test subjects suffered "serious adverse events."

Following this news, NASDAQ: AGRX fell 74% from its close in after-hours trading on January 3, 2016.

If you were negatively impacted by your investment in Agile Therapeutics Inc securities between March 9, 2016 and January 3, 2017 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185